Global Advanced Parenteral Medical Nutrition Market Size (2024-2030)

In 2023, the Global Advanced Parenteral Medical Nutrition Market reached a valuation of $3.08 billion, with a projected market size set to reach $5.93 billion by 2030. Throughout the forecast period spanning 2024 to 2030, the market is expected to exhibit a steady growth trajectory at a CAGR of 9.84%.

Overview of the Advanced Parenteral Medical Nutrition Market:

Advanced Parenteral Medical Nutrition involves the direct injection of food into a patient's veins as a medical procedure. This nutrition comprises essential elements such as proteins, carbohydrates, fats, minerals, vitamins, and electrolytes. It is primarily administered to patients incapable of naturally absorbing food and nutrients through oral intake, thereby mitigating the risks of malnutrition. Given that the patient's digestive system remains non-functional during parenteral feeding, meticulous attention is necessary to ensure that the diet is appropriately prepared to avoid digestive complications, which could significantly impact their recovery.

Over time, the Advanced Parenteral Medical Nutrition market has witnessed significant evolution, marked by enhanced safety and accessibility, owing to the integration of advanced technologies within the healthcare sector. The process has been streamlined, reducing the likelihood of infections and incorporating improved infection control measures in the years ahead.

Impact of COVID-19 on the Advanced Parenteral Medical Nutrition Market:

The advent of the COVID-19 pandemic had profound repercussions on economies and industries globally, with various countries witnessing lockdowns and widespread business closures. Notably, the healthcare and pharmaceutical sectors faced significant disruptions, including supply chain interruptions, technological setbacks, and office closures. These disruptions, in turn, impeded the overall growth of the market in three major facets: production and demand, financial repercussions on manufacturing, and supply chain disturbances. Additionally, the pandemic-induced sedentary lifestyles, resulting from lockdowns and subsequent restrictions, exposed individuals to environments conducive to diseases. Governments and regulatory bodies worldwide have responded by updating guidelines concerning the provision of nutrition and sustenance to COVID-19 patients. This concerted effort is anticipated to marginally boost the growth of the global advanced parenteral nutrition market within the forecast period of 2024-2028.

Market Drivers:

Rising Prevalence of Malnutrition, Especially Among Children:

The escalating incidence of malnutrition, particularly among children, is poised to propel market growth. Globally, as per a report by the World Health Organization and the United Nations Children’s Fund (UNICEF), published in June 2021, staggering figures reveal the prevalence of obesity, underweight conditions, stunting, wasting, and obesity among children under five years. Approximately 45% of deaths in this age group are attributed to malnutrition, underscoring the positive impact on the global advanced parenteral medical nutrition market's growth trajectory.

Governmental Initiatives and Guidelines to Enhance Medical Nutrition Facilities:

A surge in governmental initiatives aimed at bolstering medical nutrition facilities is expected to bolster market growth. Numerous medical authorities and governmental bodies are issuing directives to enhance medical facilities and fortify the overall healthcare system.

Increased Investments in the Healthcare Sector:

The burgeoning investments in the healthcare sector are instrumental in enhancing infrastructure, with government organizations implementing diverse strategies and initiatives to elevate the global healthcare landscape.

Rising Geriatric Population Driving Demand for Advanced Parenteral Medical Nutrition:

The expanding geriatric demographic is a key factor driving market growth. With aging populations experiencing a rise in bowel movement disorders and decreased digestive efficiency, the demand for advanced parenteral nutrition is on the ascent. Seniors are increasingly turning to this method for proper food intake, thereby fueling market expansion.

Market Restraints:

Lack of Healthcare Awareness in Developing and Underdeveloped Regions:

Market growth is impeded in developing and underdeveloped nations due to lower levels of healthcare awareness. In these regions, many individuals neglect routine health check-ups and possess limited knowledge regarding associated health complications. This lack of awareness poses challenges for market players, restricting profitability in these regions and hindering the overall growth of the advanced parenteral medical nutrition market.

Advanced Parenteral Medical Nutrition Market – By Nutrient Category.

• Carbohydrates
• Lipid Emulsion for Parenteral Use
• Single Dose Amino Acid Formulations
• Vitamins & Minerals
• Trace Elements

The global advanced parenteral medical nutrition market is categorized into five segments based on nutrient type: Carbohydrates, Lipid Emulsion for Parenteral Use, Single Dose Amino Acid Formulations, Vitamins & Minerals, and Trace Elements.

As of 2022, the Single Dose Amino Acid Formulations segment leads the market with a share of more than 30.5% in terms of revenue. These formulations, composed of mixed amino acids, provide both essential and nonessential amino acids, thereby serving as a comprehensive parenteral medical nutrition solution for overall bodily functions.

Projections indicate that the Lipid Emulsion for Parenteral Use segment will experience the fastest growth during the forecast period. This growth is attributed to the increasing preference for parenteral nutrition over enteral nutrition among COVID-19 patients, resulting in shorter hospital stays and decreased infection risks, thus bolstering the segment's expansion.

Advanced Parenteral Medical Nutrition Market – By Geographic Region.

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

The global advanced parenteral medical nutrition market is segmented into five major regions: North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa.

North America is poised to maintain its dominance in the global advanced parenteral nutrition market throughout the forecast period, driven by a surge in product launches and approvals.

Moreover, substantial investments in manufacturing facilities by key market players are expected to propel remarkable growth in the global parenteral medical nutrition market in Europe over the forecast period.

Advanced Parenteral Medical Nutrition Market – Key Industry Players.

1. Baxter
2. Allergan
3. Actavis Inc.
4. Otsuka Pharmaceutical Factory, Inc.
5. Grifols, S.A.
6. B. Braun Melsungen AG
7. ViforPharma
8. Fresenius Kabi AG
9. Sichuan Kelun Pharmaceutical Co., Ltd.
10. Pfizer Inc. (Hospira Inc.)

Continuous innovation and significant investments from key industry players in the development of advanced Parenteral Medical Nutrition solutions have positioned them to gain a competitive edge in the market, thereby fostering global market growth.

Recent Noteworthy Industry Developments:

In January 2020, Fresenius Kabi concluded clinical trials for SmofKabiven, a new addition to their lipid emulsions range. This move aims to enhance their existing product portfolio and maintain a strong market position.